InMode INMD
NASDAQ INMD
$14.79 -0.02 (-0.14%)
As of: Sep 9, 2026 · 3:59 PM EDT

InMode (INMD) Net Income towards Common Stockholders (2018 - 2026)

InMode's (INMD) quarterly Net Income towards Common Stockholders came in at $17.1 million in Q2 2026, down 36.19% year-over-year from $26.7 million in Q2 2025, and up 47.59% quarter-over-quarter from $11.6 million in Q1 2026.

Analysis

InMode (INMD) Net Income towards Common Stockholders (2018 - 2026) Analysis & Trends

InMode has disclosed Net Income towards Common Stockholders across 9 years of filings, most recently posting $17.1 million for Q2 2026.

  • In Q2 2026, Net Income towards Common Stockholders fell 36.19% year-over-year to $17.1 million; the TTM figure through Jun 2026 stood at $86.0 million (up 10.91% YoY), while the FY2025 annual figure was $126.8 million, up 20.03% from the prior year.
  • Net Income towards Common Stockholders came in at $17.1 million for Q2 2026 at InMode, up from $11.6 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $65.2 million in Q4 2023 to a low of -$18.4 million in Q4 2024.
  • Average Net Income towards Common Stockholders over 5 years is $32.3 million, with a median of $33.3 million recorded in 2022.
  • Year-over-year, Net Income towards Common Stockholders plunged 128.16% in 2024 and soared 293.77% in 2025.
  • Over 5 years, Net Income towards Common Stockholders stood at $37.7 million in 2022, then surged by 72.81% to $65.2 million in 2023, then slumped by 128.16% to -$18.4 million in 2024, then soared by 293.77% to $35.6 million in 2025, then sank by 52.01% to $17.1 million in 2026.
  • Per Business Quant data, the three most recent Net Income towards Common Stockholders figures were $17.1 million in Q2 2026, $11.6 million in Q1 2026, and $35.6 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn 928.00 Mn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn 823.20 Mn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn 1.48 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn 1.28 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn 907.00 Mn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn 241.40 Mn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn -
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn 249.10 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn 201.00 Mn
10 InMode 955.60 Mn 473.48 Mn 71.52 Mn 17.06 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 17.06 Mn
Mar 31, 2026 11.56 Mn
Dec 31, 2025 35.56 Mn
Sep 30, 2025 21.86 Mn
Jun 30, 2025 26.74 Mn
Mar 31, 2025 18.20 Mn
Dec 31, 2024 -18.35 Mn
Sep 30, 2024 50.99 Mn
Jun 30, 2024 23.82 Mn
Mar 31, 2024 23.70 Mn
Dec 31, 2023 65.16 Mn
Sep 30, 2023 46.52 Mn
Jun 30, 2023 55.73 Mn
Mar 31, 2023 40.51 Mn
Dec 31, 2022 37.71 Mn
Sep 30, 2022 48.79 Mn
Jun 30, 2022 44.05 Mn
Mar 31, 2022 30.98 Mn
Dec 31, 2021 52.69 Mn
Sep 30, 2021 44.72 Mn